McKinstry Nancy (CIK 1294731) reported 16 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-05-21). Recent activity: Buy MDLZ (3,525 shares), Buy ACN (12 shares), Buy ABT (2,286 shares), Buy ACN (7 shares), Sell ACN (4 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-21 | Mondelez International, Inc. (MDLZ) | Director | Buy | 3,525 | $0 |
| 2026-05-19 | Accenture plc (ACN) | Director | Buy | 12 | $0 |
| 2026-04-28 | ABBOTT LABORATORIES (ABT) | Director | Buy | 2,286 | $0 |
| 2026-02-17 | Accenture plc (ACN) | Director | Buy | 7 | $0 |
| 2026-02-17 | Accenture plc (ACN) | Director | Sell | 4 | $896 |
| 2026-02-10 | Accenture plc (ACN) | Director | Sell | 398 | $94,147 |
| 2026-01-29 | Accenture plc (ACN) | Director | Buy | 1,212 | $0 |
| 2025-11-18 | Accenture plc (ACN) | Director | Buy | 6 | $0 |
| 2025-08-18 | Accenture plc (ACN) | Director | Buy | 5 | $1,238 |
| 2025-05-22 | Mondelez International, Inc. (MDLZ) | Director | Buy | 3,009 | $0 |
| 2025-05-16 | Accenture plc (ACN) | Director | Buy | 4 | $0 |
| 2025-04-29 | ABBOTT LABORATORIES (ABT) | Director | Buy | 1,635 | $0 |
| 2025-02-18 | Accenture plc (ACN) | Director | Buy | 4 | $0 |
| 2025-02-18 | Accenture plc (ACN) | Director | Sell | 2 | $778 |
| 2025-02-07 | Accenture plc (ACN) | Director | Buy | 813 | $0 |
| 2025-02-04 | Accenture plc (ACN) | Director | Sell | 419 | $160,611 |
Source: SEC Form 4 filings · as of 2026-05-21